# Impedance Cardiography to Decrease the Risk of Preeclampsia

> **NCT03245970** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of Tennessee Medical Center**

## Conditions studied

- Chronic Hypertension Complicating Pregnancy (Diagnosis)
- Preeclampsia

## Interventions

- **DRUG:** Labetalol Hydrocholoride 200 mg orally every 12 hours
- **DRUG:** Nifedipine 60 mg orally daily
- **DRUG:** Atenolol 25 mg daily

## Key facts

- **NCT ID:** NCT03245970
- **Lead sponsor:** University of Tennessee Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-04-24
- **Primary completion:** 2020-02-29
- **Final completion:** 2020-02-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator retired. Other investigators did not want to continue study.
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03245970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03245970, "Impedance Cardiography to Decrease the Risk of Preeclampsia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03245970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*